首页|期刊导航|药物分析学报(英文)|Multiple roles of arsenic compounds in phase separation and membraneless organelles formation determine their therapeutic efficacy in tumors

Multiple roles of arsenic compounds in phase separation and membraneless organelles formation determine their therapeutic efficacy in tumorsOA

Multiple roles of arsenic compounds in phase separation and membraneless organelles formation determine their therapeutic efficacy in tumors

英文摘要

Arsenic compounds are widely used for the therapeutic intervention of multiple diseases.Ancient pharmacologists discovered the medicinal utility of these highly toxic substances,and modern phar-macologists have further recognized the specific active ingredients in human diseases.In particular,Arsenic trioxide(ATO),as a main component,has therapeutic effects on various tumors(including leukemia,hepatocellular carcinoma,lung cancer,etc.).However,its toxicity limits its efficacy,and con-trolling the toxicity has been an important issue.Interestingly,recent evidence has pointed out the pivotal roles of arsenic compounds in phase separation and membraneless organelles formation,which may determine their toxicity and therapeutic efficacy.Here,we summarize the arsenic compounds-regulating phase separation and membraneless organelles formation.We further hypothesize their potential involvement in the therapy and toxicity of arsenic compounds,highlighting potential mecha-nisms underlying the clinical application of arsenic compounds.

Meiyu Qu;Qiangqiang He;Hangyang Bao;Xing Ji;Tingyu Shen;Muhammad Qasim Barkat;Ximei Wu;Ling-Hui Zeng

Department of Pharmacy,Second Hospital of Shanxi Medical University,Taiyuan,030001,ChinaDepartment of Pharmacology,Zhejiang University School of Medicine,Hangzhou,310058,ChinaDepartment of Pharmacology,Hangzhou City University School of Medicine,Hangzhou,310015,China

Arsenic compoundsPhase separationMembraneless organellesPMLStress granules

《药物分析学报(英文)》 2024 (008)

1110-1124 / 15

The authors are grateful for the financial support from the Na-tional Natural Science Foundation of China(Grant Nos.:31571493,81741043,31871395,and 32170841).

10.1016/j.jpha.2024.02.011

评论